# INTERVIEW: Optibiotix Health Plc Names Tata Chemicals Limited as the large Asian market multi-national

- Link: https://www.directorstalkinterviews.com/interview-optibiotix-health-plc-names-tata-chemicals-limited-large-asian-market-multi-national/412723340
- Published: 2017-02-07T12:33:27+00:00
- Author: Giles Arbor

**Optibiotix Health Plc** (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about
a string of news since Christmas, Stephen gives us an overview of the company’s 
progress and plans for 2017.

 

In December 2016 OptiBiotix Health plc announced that it has entered into a joint
development agreement with a multinational. The multinational is a major supplier
of nutritional solutions to the food, beverage, nutraceutical and pharmaceutical
industries within Asia, and increasingly across global markets. In this exclusive
interview CEO Stephen O’Hara now names the company as **Tata Chemicals Limited (
Parent)** (NSE:TATACHEM). At the time all we knew was that the aim of the Agreement
was to develop weight management products containing SlimBiome® technology in a 
range of foods and OTC products which, if successful, would be launched into the
Asian market in the second half of 2017. Stephen now sheds further light on this.

The company has established a pipeline of microbiome modulators that can impact 
on lipid and cholesterol management, energy harvest and appetite suppression. The
development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform
technologies designed to identify metabolic pathways and compounds that impact on
human physiology and bring potential health benefits. These platforms are applicable
across a wider range of other human diseases.

Share on: